AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: Results from the Singapore HIV Observational Cohort Study (SHOCS)

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Bellamy, Richard ^a,b,c   Sangeetha, S ^a   Paton, Nicholas I ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KINTAMPO HEALTH RESEARCH CENTRE   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AIDS RELATED COMPLEX; ARTICLE; COHORT ANALYSIS; DATA ANALYSIS; HEALTH CARE PERSONNEL; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; RETINITIS; RETROSPECTIVE STUDY; SINGAPORE; ATYPICAL MYCOBACTERIOSIS; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS RETINITIS; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS RETINITIS; HERPES SIMPLEX; HUMANS; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; SINGAPORE; TUBERCULOSIS;

EID: 10144230775     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-4-47     Document Type: Article

References (38)

1. Pezzotti P, Serraino D, Rezza G, Dal Maso L, Vaccher E, Lepri AC, Franceschi S. The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996. Int J Epidemiol 1999;28: 975-981.
2. Lundgren JD, Phillips AN, Pedersen C, Clumeck N, Gatell JM, Johnson AM, Ledergerber B, Vella S, Nielsen JO, for the AIDS in Europe Study Group: Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. JAMA 1994,271: 088-1092.
3. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, Winkelstein WW, Cooper DA, Craib KJP, Charlebois E, Coutinho RA, van Griensven GJP: Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994,140:747-758.
4. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M, and the Swiss HIV Cohort Study: Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 1997,315:1194-1199.
5. Phillips AN, Katlama C, Barton S, Vella S, Blaxhult A, Clotet B, Goebel F-D, Hirschel B, Pedersen C, Lundgren JD, for the EUROSIDA Study Group: Survival of 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. J AIDS Hum Retrovirol 1998,17:239-244.
6. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD, for the EUROSIDA Study Group: Changing patterns of mortality across Europe in patients with HIV-1. Lancet 1998, 352:1725-1730.
7. Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, Katzenstein T, van Lunzen J, Antunes F, Phillips AN, Lundgren JD, for the EUROSIDA study group: Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med 1999,130:570- 577.
8. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, d'Arminio Monforte A, Ledergerber B, Lundgren JD, for the EUROSIDA Study Group: Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS 1999,13:943-950.
9. Chiesi A, Mocroft A, Dally LG, Miller V, Katlama C, Ledergerber B, Pedersen C, Phillips AN, Arcieri R, Lundgren JD, for the EUROSIDA Study Group: Regional survival differences across Europe in HIV-positive people: the EuroSIDA study. AIDS1999,13:2281-2288.
10. Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, Chiesi A, Phillips AN, Kirk O, Lundgren JD, for the EUROSIDA Study Group: AIDS across Europe, 1994-1998: the EuroSIDA study. Lancet 2000,356:291-296.
11. Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antunes F, Lundgren JD, Clotet B, for the EUROSIDA Study Group: Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe. Results from the EuroSIDA study. Arch Intern Med 2000,160:1123-1132.
12. Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, Barton SE, Sudre P, Phillips AN, Lundgren JD, for the EUROSIDA Study Group: Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. Am J Respir Crit Care Med 2000,162: 65-872.
13. Viard J-P, Mocroft A, Chiesi A, Kirk O, Roge B, Panos G, Vetter N, Bruun JN, Johnson M, Lundgren JD, for the EUROSIDA Study Group: Influence of age on CD4 cell recovery in human immunodeficiency-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis 2001, 183:1290-1294.
14. Mocroft A, Phillips AN, Miller V, Gatell J, van Lunzen J, Parkin JM, Weber R, Roge B, Lazzarin A, Lundgren JD, on behalf of the EUROSIDA Study Group: The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study. AIDS 2001,15:201-209.
15. Lundgren JD, Mocroft A, Gatell JM, Ledergerber B, D'Arminio Monforte A, Hermans P, Goebel F-D, Blaxnult A, Kirk O, Phillips AN, for the EUROSIDA Study Group: A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study. J Infect Dis 2002,185:178-187.
16. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, d'Arminio Monforte A, Fox Z, Lundgren JD, for the EUROSIDA Study Group: Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002,16:1663-1671.
17. Montaner JSG, Le TN, Le N, Craib KJP, Schechter MT: Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS 1992,6:719-724.
18. Stein DS, Graham NMH, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ, for the Multicenter AIDS Cohort Study: The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. Ann Intern Med 1994,121:100-108.
19. Gallant JE, Moore RD, Keruly J, Richman DD, Chaisson RE, and the Zidovudine Epidemiology Study Group: Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1995,172:346-352.
20. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD, and the HIV Outpatient Study Investigators: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998,338:853-860.
21. Hogg RS, Heath KV, Yip B, Craib KJP, O'Shaughnessy MVO, Schechter MT, Montaner JSG: Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998,279:450-454.
22. Chequer P, Hearst N, Hughes ES, Castilho E, Rutherford G, Loures L, Rodrigues L and the Brazilian State AIDS Program Coordinators: Determinants of survival in adult Brazilian AIDS patients, 1982-1989. AIDS 1992,6:483-487.
23. Fonseca LAM, Reingold AL, Casseb JR, Brigido LFM, Duarte AJS: AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in Sao Paolo, Brazil. Int J Epidemiol 1999,28:1156-1160.
24. Lifson AR, Allen S, Wolf, Serufilira A, Kantarama G, Lindan CP, Hudes ES, Nsengumuremyi F, Taelman H, Batnugwanayo J: Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization staging system and recommended modifications. Ann Intern Med 1995,122: 62-270.
25. Anzala OA, Nico JD, Nagelkerke NJD, Bwayo JJ, Holton D, Moses S, Ngugi EN, Ndinya-Achola JO, Plummer FA: Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995,171:686-689.
26. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner H-U, Mulder DW, Whitworth JA: HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997,350:245-250.
27. Morgan D, Malamba SS, Maude GH, Okongo MJ, Wagner H-U, Mulder DW, Whitworth JA: An HIV-1 natural history cohort and survival times in rural Uganda. AIDS 1997,11:633-640.
28. Okongo M, Morgan D, Mayanja B, Ross A, Whitworth J: Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. Int J Epidemiol 1998,27:698-702.
29. Malamba SS, Morgan D, Clayton T, Mayanja B, Okongo M, Whitworth J: The prognostic value of the World Health Organization staging system for HIV infection and disease in rural Uganda. AIDS 1999,13:2555-2562.
30. Sewenkambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire-Mangen F, Nalugoda F, Kiwanuka N, Lutalo T, Kigozi G, Chuanjun L, Meehan MP, Brahmbatt H, Wawer MJ: Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS 2000,14:2391-2400.
31. Post FA, Badri M, Wood R, Maartens G: AIDS in Africa- survival according to AIDS-defining illness. S Afr Med J2001, 91:583-586.
32. Morgan D, Mahe C, Mayanja B, Whitworth JAG: Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ 2002,324:193-197.
33. Kitayaporn D, Tansuphaswadikul S, Lohsomboon P, Pannachet K, Kaewkungwal J, Limpakarnjanarat K, Mastro TD: Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. J AIDS Hum Retrovirol 1996,11:77-82.
34. Bellamy R, Sangeetha S, Paton NI: Causes of death among patients with HIV in Singapore, from 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). HIV Medicine 2004,5:289-295.
35. Centers for Disease Control and Prevention: 1993 Classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992,41(RR-17):1-19.
36. Tansuphasawadikul S, Amornkul PN, Tanchanpong C, Limpakarnjanarat K, Kaewkungwal J, Likanonsakul S, Eampokalap B, Naiwatanakul T, Kitayaporn D, Young NL, Hu DJ, Mastro TD: Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand. J AIDS 1999,21:326-332.
37. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, Costagliola D, d'Arminio Monforte A, de Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B, Sterne JAC, and the ART Cohort Collaboration: Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002, 360:119-129.
38. Miller V, Phillips AN, Clotet B, Mocroft A, Ledergerber B, Kirk O, Ormaasen V, Gargalianos-Kakolyris P, Vella S, Lundgren JD, for the EUROSIDA Study Group: Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts. J Infect Dis 2002,186:189-197.